Literature DB >> 32717379

Non-specific orbital inflammation: Current understanding and unmet needs.

Min Joung Lee1, Stephen R Planck2, Dongseok Choi3, Christina A Harrington4, David J Wilson2, Roger A Dailey2, John D Ng2, Eric A Steele2, Bronwyn E Hamilton5, Sang In Khwarg6, James T Rosenbaum7.   

Abstract

Non-specific orbital inflammation (NSOI) is a noninfectious inflammatory condition of the orbit. Although it is generally considered the most common diagnosis derived from an orbital biopsy, it is a diagnosis of exclusion, meaning that the diagnosis requires exclusion of a systemic process or another identifiable etiology of orbital inflammation. The clinical diagnosis of NSOI is ill-defined, but it is typically characterized by acute orbital signs and symptoms, including pain, proptosis, periorbital edema, chemosis, diplopia, and less commonly visual disturbance. NSOI poses a diagnostic and therapeutic challenge: The clinical presentations and histological findings are heterogeneous, and there are no specific diagnostic criteria or treatment guidelines. The etiology and pathogenesis of NSOI are poorly understood. Here we recapitulate our current clinical understanding of NSOI, with an emphasis on the most recent findings on clinical characteristics, imaging findings, and treatment outcomes. Furthermore, gene expression profiling of NSOI and its implications are presented and discussed.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Gene-expression profiling; Granulomatosis with polyangiitis; IgG4-related ophthalmic diseases; Nonspecific orbital inflammation; Orbital sarcoidosis; Thyroid eye disease

Year:  2020        PMID: 32717379     DOI: 10.1016/j.preteyeres.2020.100885

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  6 in total

Review 1.  Idiopathic Orbital Myositis Revisited.

Authors:  Ilse Mombaerts; Alan A McNab
Journal:  Curr Rheumatol Rep       Date:  2022-02-09       Impact factor: 4.592

2.  Identification of Hub Genes Associated with Nonspecific Orbital Inflammation by Weighted Gene Coexpression Network Analysis.

Authors:  Hanhan Liu; Lu Chen; Xiang Lei; Hong Ren; Gaoyang Li; Zhihong Deng
Journal:  Dis Markers       Date:  2022-05-27       Impact factor: 3.464

3.  Clinical heterogeneity between two subgroups of patients with idiopathic orbital inflammation.

Authors:  Toshinobu Kubota; Akari Iwakoshi
Journal:  BMJ Open Ophthalmol       Date:  2022-06

4.  Severe outcome of idiopathic inflammatory mass lesions primarily located in the posterior orbit and orbital apex.

Authors:  Kamil G Laban; Rachel Kalmann; Roos J Leguit; Peter H Uijttewaal; Timothy R D J Radstake; Joke H de Boer; Rob L P van der Veen
Journal:  Acta Ophthalmol       Date:  2020-10-29       Impact factor: 3.761

5.  Correlation Between IVIM-DWI Parameters and Pathological Classification of Idiopathic Orbital Inflammatory Pseudotumors: A Preliminary Study.

Authors:  Jian Pu; Yi Liang; Qian He; Ju-Wei Shao; Min-Jie Zhou; Shu-Tian Xiang; Ying-Wen Li; Jian-Bo Li; Shun-Jun Ji
Journal:  Front Oncol       Date:  2022-03-11       Impact factor: 6.244

6.  Evaluation of Orbital Lymphoproliferative and Inflammatory Disorders by Gene Expression Analysis.

Authors:  Karim Al-Ghazzawi; Sven Holger Baum; Roman Pförtner; Svenja Philipp; Nikolaos Bechrakis; Gina Görtz; Anja Eckstein; Fabian D Mairinger; Michael Oeverhaus
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.